Commerce Threat To Claim University Patents Sparks Innovation Worries

Bayh-Dole Act advocates warn that the Commerce Department’s effort to claim partial ownership of university-held patents could reduce filings and dramatically slow innovation of medical products like immunotherapies and mRNA vaccines, but one patent expert tells Inside Health Policy reducing the number of low-value patents could clear the way for more researchers and companies to develop new therapies without negotiating dozens of overlapping licenses.